These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 11054435)

  • 1. Durable remission after aggressive chemotherapy for very late post-kidney transplant lymphoproliferation: A report of 16 cases observed in a single center.
    Mamzer-Bruneel MF; Lomé C; Morelon E; Levy V; Bourquelot P; Jacobs F; Gessain A; Mac Intyre E; Brousse N; Kreis H; Hermine O
    J Clin Oncol; 2000 Nov; 18(21):3622-32. PubMed ID: 11054435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-transplant lymphoproliferative disorders: improved outcome after clinico-pathologically tailored treatment.
    Muti G; Cantoni S; Oreste P; Klersy C; Gini G; Rossi V; D'Avanzo G; Comoli P; Baldanti F; Montillo M; Nosari A; Morra E;
    Haematologica; 2002 Jan; 87(1):67-77. PubMed ID: 11801467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage chemotherapy for refractory and relapsed posttransplant lymphoproliferative disorders (PTLD) after treatment with single-agent rituximab.
    Trappe R; Riess H; Babel N; Hummel M; Lehmkuhl H; Jonas S; Anagnostopoulos I; Papp-Vary M; Reinke P; Hetzer R; Dörken B; Oertel S
    Transplantation; 2007 Apr; 83(7):912-8. PubMed ID: 17460562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkitt post-transplantation lymphoma in adult solid organ transplant recipients: sequential immunochemotherapy with rituximab (R) followed by cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or R-CHOP is safe and effective in an analysis of 8 patients.
    Zimmermann H; Reinke P; Neuhaus R; Lehmkuhl H; Oertel S; Atta J; Planker M; Gärtner B; Lenze D; Anagnostopoulos I; Riess H; Trappe RU
    Cancer; 2012 Oct; 118(19):4715-24. PubMed ID: 22392525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab therapy and reduction of immunosuppression to rescue graft function after renal posttransplantation lymphoproliferative disorder found by macrohematuria in a pancreas and kidney transplant recipient: a case report.
    Miyagi S; Sekiguchi S; Kawagishi N; Akamatsu Y; Satoh K; Takeda I; Fukushima D; Kobayashi Y; Tokodai K; Fujimori K; Satomi S
    Transplant Proc; 2011 Nov; 43(9):3299-301. PubMed ID: 22099782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphoproliferative disorders after organ transplantation: a report of 24 cases observed in a single center.
    Leblond V; Sutton L; Dorent R; Davi F; Bitker MO; Gabarre J; Charlotte F; Ghoussoub JJ; Fourcade C; Fischer A
    J Clin Oncol; 1995 Apr; 13(4):961-8. PubMed ID: 7707124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial.
    Trappe R; Oertel S; Leblond V; Mollee P; Sender M; Reinke P; Neuhaus R; Lehmkuhl H; Horst HA; Salles G; Morschhauser F; Jaccard A; Lamy T; Leithäuser M; Zimmermann H; Anagnostopoulos I; Raphael M; Riess H; Choquet S; ;
    Lancet Oncol; 2012 Feb; 13(2):196-206. PubMed ID: 22173060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive treatment for postcardiac transplant lymphoproliferation.
    Swinnen LJ; Mullen GM; Carr TJ; Costanzo MR; Fisher RI
    Blood; 1995 Nov; 86(9):3333-40. PubMed ID: 7579436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late-onset post-transplantation lymphoproliferative disorders after kidney transplantation: a monocentric study over three decades.
    Michonneau D; Suarez F; Lambert J; Adam J; Brousse N; Canioni D; Anglicheau D; Martinez F; Snanoudj R; Legendre C; Hermine O; Mamzer-Bruneel MF
    Nephrol Dial Transplant; 2013 Feb; 28(2):471-8. PubMed ID: 23129824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Posttransplant lymphoma--a single-center experience of 500 liver transplantations.
    Norin S; Kimby E; Ericzon BG; Christensson B; Sander B; Söderdahl G; Hägglund H
    Med Oncol; 2004; 21(3):273-84. PubMed ID: 15456956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB; Wang Y; Song QJ; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):607-12. PubMed ID: 23157829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fludarabine, cyclophosphamide, doxorubicin (FCD), and rituximab: a remission induction therapy for aggressive pediatric post-transplant lymphoproliferative disease (PTLD).
    Giraldi E; Provenzi M; Fiocchi R; Colledan M; Cornelli P; Torre G; Rambaldi A; Conter V
    Pediatr Blood Cancer; 2011 Aug; 57(2):324-8. PubMed ID: 21294246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S; Zafar MN; Best J; Reddy HK
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):77-83. PubMed ID: 16703222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tailored chemotherapy for malignant lymphoma arising in the setting of posttransplant lymphoproliferative disorder after solid organ transplantation.
    Watts RG; Hilliard LM; Berkow RL
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):622-6. PubMed ID: 12439033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Posttransplant lymphoproliferative disorder in a kidney-pancreas transplanted recipient: simultaneous development of clonal lymphoid B-cell proliferation of host and donor origin.
    Heyny-von Haussen R; Klingel K; Riegel W; Kandolf R; Mall G
    Am J Surg Pathol; 2006 Jul; 30(7):900-5. PubMed ID: 16819335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-transplantation lymphoproliferative disorder of recipient origin in a boy with acute T-cell leukemia with detection of B-cell clonality 3 months before stem cell transplantation.
    Kontny U; Boppana S; Jung A; Goebel H; Strahm B; Peters A; Dormann S; Werner M; Bader P; Fisch P; Niemeyer C
    Haematologica; 2005 Nov; 90 Suppl():ECR27. PubMed ID: 16266918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-transplant lymphoproliferative diseases in Asian solid organ transplant recipients: late onset and favorable response to treatment.
    Chan TS; Hwang YY; Gill H; Au WY; Leung AY; Tse E; Chim CS; Loong F; Kwong YL
    Clin Transplant; 2012; 26(5):679-83. PubMed ID: 22324300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable remission after aggressive chemotherapy for post-cardiac transplant lymphoproliferation.
    Swinnen LJ
    Leuk Lymphoma; 1997 Dec; 28(1-2):89-101. PubMed ID: 9498708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indications and results of chemotherapy in children with posttransplant lymphoproliferative disease after liver transplantation.
    Smets F; Vajro P; Cornu G; Reding R; Otte JB; Sokal E
    Transplantation; 2000 Mar; 69(5):982-4. PubMed ID: 10755561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of 18 children with aggressive mature B-cell lymphoma after liver transplantation].
    Zhao JC; Feng MX; Su M; Han YL; Xue F; Tang YJ; Zhang AA; Tang JY; Gao YJ
    Zhonghua Er Ke Za Zhi; 2024 Jun; 62(6):553-558. PubMed ID: 38763878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.